24349175|t|Ginkgo biloba extract individually inhibits JNK activation and induces c-Jun degradation in human chondrocytes: potential therapeutics for osteoarthritis.
24349175|a|Osteoarthritis (OA) is a common joint disorder with varying degrees of inflammation. The ideal anti-OA drug should have immunomodulatory effects while at the same time having limited or no toxicity. We examined the anti-inflammatory effects of Ginkgo biloba extract (EGb) in interleukin-1 (IL-1)-stimulated human chondrocytes. Chondrocytes were prepared from cartilage specimens taken from patients with osteoarthritis who had received total hip or total knee replacement. The concentrations of chemokines and the degree of cell migration were determined by ELISA and chemotaxis assays, respectively. The activation of inducible nitric oxide synthase (iNOS), mitogen-activated protein kinases (MAPKs), activator protein-1 (AP-1), and nuclear factor-kappaB (NF-kappaB) was determined by immunoblotting, immunohistochemistry, and electrophoretic mobility shift assay. We found that EGb inhibited IL-1-induced production of chemokines, which in turn resulted in attenuation of THP-1 cell migration toward EGb-treated cell culture medium. EGb also suppressed IL-1-stimulated iNOS expression and release of nitric oxide (NO). The EGb-mediated suppression of the iNOS-NO pathway correlated with the attenuation of activator protein-1 (AP-1) but not nuclear factor-kappaB (NF-kappaB) DNA-binding activity. Of the mitogen-activated protein kinases (MAPKs), EGb inhibited only c-Jun N-terminal kinase (JNK). Unexpectedly, EGb selectively caused degradation of c-Jun protein. Further investigation revealed that EGb-mediated c-Jun degradation was preceded by ubiquitination of c-Jun and could be prevented by the proteosome inhibitor MG-132. The results imply that EGb protects against chondrocyte degeneration by inhibiting JNK activation and inducing ubiquitination-dependent c-Jun degradation. Although additional research is needed, our results suggest that EGb is a potential therapeutic agent for the treatment of OA. 
24349175	44	47	JNK	Gene	5599
24349175	71	76	c-Jun	Gene	3725
24349175	92	97	human	Species	9606
24349175	139	153	osteoarthritis	Disease	MESH:D010003
24349175	155	169	Osteoarthritis	Disease	MESH:D010003
24349175	171	173	OA	Disease	MESH:D010003
24349175	187	201	joint disorder	Disease	MESH:D007592
24349175	226	238	inflammation	Disease	MESH:D007249
24349175	255	257	OA	Disease	MESH:D010003
24349175	344	352	toxicity	Disease	MESH:D064420
24349175	375	387	inflammatory	Disease	MESH:D007249
24349175	422	425	EGb	Chemical	-
24349175	430	443	interleukin-1	Gene	3552
24349175	445	449	IL-1	Gene	3552
24349175	462	467	human	Species	9606
24349175	545	553	patients	Species	9606
24349175	559	573	osteoarthritis	Disease	MESH:D010003
24349175	774	805	inducible nitric oxide synthase	Gene	4843
24349175	807	811	iNOS	Gene	4843
24349175	857	876	activator protein-1	Gene	3725
24349175	878	882	AP-1	Gene	3725
24349175	889	910	nuclear factor-kappaB	Gene	4790
24349175	912	921	NF-kappaB	Gene	4790
24349175	1049	1053	IL-1	Gene	3552
24349175	1129	1134	THP-1	CellLine	CVCL:0006
24349175	1190	1193	EGb	Chemical	-
24349175	1210	1214	IL-1	Gene	3552
24349175	1226	1230	iNOS	Gene	4843
24349175	1257	1269	nitric oxide	Chemical	MESH:D009569
24349175	1312	1316	iNOS	Gene	4843
24349175	1363	1382	activator protein-1	Gene	3725
24349175	1384	1388	AP-1	Gene	3725
24349175	1398	1419	nuclear factor-kappaB	Gene	4790
24349175	1421	1430	NF-kappaB	Gene	4790
24349175	1523	1546	c-Jun N-terminal kinase	Gene	5599
24349175	1548	1551	JNK	Gene	5599
24349175	1606	1611	c-Jun	Gene	3725
24349175	1670	1675	c-Jun	Gene	3725
24349175	1722	1727	c-Jun	Gene	3725
24349175	1779	1785	MG-132	Chemical	MESH:C072553
24349175	1831	1855	chondrocyte degeneration	Disease	MESH:D009410
24349175	1870	1873	JNK	Gene	5599
24349175	1923	1928	c-Jun	Gene	3725
24349175	2007	2010	EGb	Chemical	-
24349175	2065	2067	OA	Disease	MESH:D010003
24349175	Negative_Correlation	MESH:C072553	3725
24349175	Association	MESH:D009410	3725
24349175	Association	MESH:D009410	5599
24349175	Association	3725	4843
24349175	Positive_Correlation	3552	4843

